Overview of Renal Replacement

Renal replacement is the use of extracorporeal blood purification to control water and solute load when the kidneys are unable to do so. Methods include:

SLED is often referred to as SLEDD, for Sustained Low-Efficiency Daily Dialysis.

I have elected to use SLED because during renal recovery second-daily (or less) use is common, and so the “daily” is a misnomer.

Principles

Physical

Principles:

  • Ultrafiltration
    Generation of a transmembrane pressure that exceeds the oncotic pressure, resulting in net loss of water across the dialysis membrane. This is achieved by:
    • Relative pressurisation of the blood relative to the dialysate, ↑ hydrostatic pressure
      Volume cleared is proportional to the transmembrane pressure.
    • ↑ Osmolality of the dialysate, drawing water across the membrane

\(TMP = {P_{Filter} + P_{Return} \over 2} - {P_{Effluent}}\)

Where:

  • \(TMP\) = Transmembrane Pressure
  • \(P\) = Pressure
  • Convection (Solvent drag)
    Passive transport of solute particles across a semipermeable membrane along with the movement of solvent.
    • Better clearance of mid-sized molecules
  • Diffusion
    Generation of an electro-chemical gradient across the membrane.
    • Rate of diffusion is affected by:
      • Molecular weight
      • Membrane porosity
      • Blood flow rate
    • Better clearance of small molecules

Values:

  • Sieving Coefficient
    Describes how effectively a given solute is removed.
    • A high value indicates effective clearance

\(SC = {[UF] \over [Blood]}\)

Where:

  • \(SC\) = Sieving coefficient
  • \(UF\) = Ultrafiltrate
  • Filtration Fraction
    Fraction of plasma removed from blood during filtration.

\(FF = {Rate_{UF} \over Rate_{Blood}} = {Rate_{UF} \over Rate_{Blood \ Pump} \times (1 - Hct)}\)

Where:

  • \(FF\) = Filtration Fraction
  • \(UF\) = Ultrafiltrate
  • \(Hct\) = Haematocrit

Practical

  • Dose
    Effluent production in mL/kg/hr.
    • CRRT dose should generally be 20-25mL/hr
      • This typically requires a prescription of 25-30mL/hr due to interruptions
      • Higher doses are not associated with improved outcome, but do ↑ the incidence of other electrolyte abnormalities
        e.g. ↓ PO4.
      • Higher doses may be used (with little evidence) in profound metabolic derangements refractory to standard RRT
        • Rhabdomyolysis with intractable hyperkalaemia
        • Liver failure to ↑ ammonia clearance
    • Hypotension and electrolyte disturbances are more common at higher intensities (dosing) and are not associated with improved outcome
    • Composition of effluent (and therefore the nature of “dose”) varies depending on the:
      • Use of pre-filter dilution
      • Mechanism of effluent production
        • Ultrafiltration
          i.e. TMP driven.
        • Diffusion
          i.e. Dialysis flow rate driven.
    • There is no good evidence suggesting which measure of weight should be used

Note this definition of dose is peculiar to CRRT; dosing intermittent dialysis is different due to the alterations in kinetics and fluid shifts that occur.

  • Fluid removal
    Difference between:
    • Effluent production
    • Pre-filter diluent
    • Post-filter replacement

Comparison of Techniques

Methods of Renal Replacement
Technique Clinical Setting Advantages Disadvantages
IHD
  • HDx stability
  • Planned for continued dialysis in ward environment
  • Rapid
  • Cheaper
  • Hypotension due to rapid volume shifts
    May delay renal recovery in the ICU patient.
  • Cerebral oedema due to rapid fluid shifts (dialysis disequilibrium syndrome)
CRRT
  • HDx instability
  • ICP
  • Technically simple(r)
  • HDx stability
  • Continuous removal of toxins
  • Slower clearance
  • Prolonged anticoagulation/immobilisation
  • Expensive
SLED
  • Encourage activity
  • HDx stability
  • Reduced anticoagulation requirement
  • Facilitates mobilisation with overnight dialysis
  • Slow clearance of toxins
  • ↑ Technical complexity
PD
  • HDx instability
  • Coagulopathic
  • Difficult venous access
  • High ICP
  • Austere setting
  • Simple
  • Cheap
  • No anticoagulation requirement
  • No vascular access requirement
  • Reduced clearance in catabolic patients
  • Protein loss
  • No control over rate of fluid removal
  • Risk of peritonitis
  • Hyperglycaemia
  • Respiratory impairment
SCUF
  • Removal of fluid
    100-500mL/hr of UF.
  • Haemodynamic stability

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl. 2012; 2: 1–138.
  2. Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.